ENTPD1 and neoplasm: AhR activation also induces CD39 and CD73, thereby increasing the conversion of ATP to adenosine [16], allowing AhR activation to raise adenosine levels from different cells of the tumour microenvironment, thereby driving A2Ar activation and contributing to ‘exhaustion’ in NK cells and CD8+ T cells.